Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 112 | 2024 | 2020 | 15.400 |
Why?
|
Papillomavirus Infections | 95 | 2024 | 1613 | 14.140 |
Why?
|
Papillomavirus Vaccines | 63 | 2024 | 496 | 12.850 |
Why?
|
Early Detection of Cancer | 61 | 2024 | 3201 | 6.430 |
Why?
|
Uterine Cervical Dysplasia | 23 | 2024 | 384 | 5.270 |
Why?
|
Cost-Benefit Analysis | 80 | 2024 | 5492 | 4.760 |
Why?
|
Papillomaviridae | 27 | 2024 | 1119 | 4.580 |
Why?
|
Mass Screening | 54 | 2024 | 5428 | 3.670 |
Why?
|
Vaccination | 41 | 2024 | 3384 | 3.470 |
Why?
|
Colposcopy | 23 | 2024 | 150 | 3.000 |
Why?
|
Human papillomavirus 16 | 21 | 2024 | 267 | 2.620 |
Why?
|
Models, Theoretical | 25 | 2024 | 3575 | 2.620 |
Why?
|
Human papillomavirus 18 | 18 | 2023 | 125 | 2.460 |
Why?
|
Vaginal Smears | 18 | 2024 | 499 | 2.420 |
Why?
|
Alphapapillomavirus | 10 | 2022 | 218 | 2.190 |
Why?
|
Health Policy | 13 | 2019 | 2684 | 1.920 |
Why?
|
Quality-Adjusted Life Years | 25 | 2023 | 1722 | 1.580 |
Why?
|
Health Care Costs | 13 | 2022 | 3242 | 1.290 |
Why?
|
Mass Vaccination | 3 | 2019 | 109 | 1.230 |
Why?
|
Computer Simulation | 14 | 2021 | 6240 | 1.190 |
Why?
|
Models, Economic | 9 | 2022 | 716 | 1.090 |
Why?
|
Personality Disorders | 4 | 2013 | 722 | 1.080 |
Why?
|
Anus Neoplasms | 5 | 2018 | 329 | 0.910 |
Why?
|
Decision Support Techniques | 6 | 2019 | 1998 | 0.890 |
Why?
|
Norway | 10 | 2024 | 499 | 0.890 |
Why?
|
Monte Carlo Method | 11 | 2021 | 1258 | 0.830 |
Why?
|
Immunization Schedule | 3 | 2024 | 227 | 0.830 |
Why?
|
Psychotherapy | 5 | 2015 | 1647 | 0.800 |
Why?
|
Female | 141 | 2024 | 392644 | 0.790 |
Why?
|
DNA, Viral | 10 | 2017 | 2202 | 0.770 |
Why?
|
Health Resources | 4 | 2017 | 935 | 0.730 |
Why?
|
Practice Guidelines as Topic | 11 | 2021 | 7390 | 0.690 |
Why?
|
Developed Countries | 4 | 2024 | 449 | 0.670 |
Why?
|
Tumor Virus Infections | 2 | 2018 | 438 | 0.670 |
Why?
|
Adult | 78 | 2024 | 221177 | 0.640 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 526 | 0.640 |
Why?
|
Uganda | 7 | 2019 | 1332 | 0.610 |
Why?
|
Humans | 155 | 2024 | 761504 | 0.600 |
Why?
|
Healthcare Disparities | 4 | 2023 | 3358 | 0.590 |
Why?
|
Incidence | 22 | 2024 | 21353 | 0.580 |
Why?
|
Developing Countries | 10 | 2020 | 2885 | 0.580 |
Why?
|
Models, Statistical | 10 | 2021 | 5079 | 0.560 |
Why?
|
Self-Examination | 1 | 2016 | 71 | 0.540 |
Why?
|
Young Adult | 36 | 2024 | 59243 | 0.530 |
Why?
|
Genital Neoplasms, Female | 2 | 2012 | 532 | 0.500 |
Why?
|
El Salvador | 4 | 2019 | 33 | 0.500 |
Why?
|
Middle Aged | 55 | 2024 | 220895 | 0.470 |
Why?
|
Immunization Programs | 2 | 2015 | 268 | 0.460 |
Why?
|
Heart Valve Diseases | 1 | 2021 | 1027 | 0.440 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 131 | 0.420 |
Why?
|
Adolescent | 39 | 2024 | 88319 | 0.410 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 422 | 0.410 |
Why?
|
Genital Neoplasms, Male | 1 | 2012 | 68 | 0.410 |
Why?
|
United States | 34 | 2024 | 72334 | 0.400 |
Why?
|
Health Status Disparities | 1 | 2023 | 1852 | 0.390 |
Why?
|
Age Factors | 12 | 2020 | 18395 | 0.390 |
Why?
|
Choice Behavior | 1 | 2017 | 824 | 0.380 |
Why?
|
Precancerous Conditions | 2 | 2017 | 980 | 0.380 |
Why?
|
Meningococcal Vaccines | 1 | 2011 | 94 | 0.370 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2011 | 40 | 0.370 |
Why?
|
Cytological Techniques | 3 | 2021 | 218 | 0.360 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1553 | 0.360 |
Why?
|
Models, Biological | 7 | 2020 | 9469 | 0.360 |
Why?
|
Population Surveillance | 3 | 2019 | 2598 | 0.360 |
Why?
|
Vulvar Neoplasms | 2 | 2013 | 263 | 0.350 |
Why?
|
Patient Compliance | 2 | 2021 | 2690 | 0.350 |
Why?
|
Selection Bias | 1 | 2011 | 359 | 0.340 |
Why?
|
Child | 29 | 2024 | 80153 | 0.340 |
Why?
|
Oropharyngeal Neoplasms | 4 | 2023 | 491 | 0.340 |
Why?
|
Cervix Uteri | 4 | 2022 | 570 | 0.330 |
Why?
|
Bayes Theorem | 1 | 2017 | 2330 | 0.320 |
Why?
|
Specimen Handling | 4 | 2021 | 702 | 0.310 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 709 | 0.310 |
Why?
|
American Cancer Society | 3 | 2024 | 69 | 0.310 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5336 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2538 | 0.280 |
Why?
|
HIV Infections | 3 | 2018 | 17351 | 0.270 |
Why?
|
Condylomata Acuminata | 3 | 2012 | 75 | 0.270 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1112 | 0.270 |
Why?
|
Cost of Illness | 3 | 2015 | 1936 | 0.270 |
Why?
|
Calibration | 2 | 2018 | 818 | 0.250 |
Why?
|
India | 3 | 2021 | 2348 | 0.240 |
Why?
|
Markov Chains | 3 | 2019 | 966 | 0.240 |
Why?
|
Uncertainty | 4 | 2024 | 754 | 0.240 |
Why?
|
Aged | 27 | 2021 | 169289 | 0.240 |
Why?
|
Public Health | 2 | 2017 | 2669 | 0.240 |
Why?
|
Time | 2 | 2020 | 546 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.240 |
Why?
|
Decision Making | 3 | 2017 | 3929 | 0.240 |
Why?
|
Netherlands | 4 | 2011 | 2221 | 0.240 |
Why?
|
Mississippi | 2 | 2021 | 95 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2017 | 4026 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2016 | 611 | 0.220 |
Why?
|
Mental Health Services | 2 | 2015 | 1730 | 0.210 |
Why?
|
Federal Government | 1 | 2024 | 267 | 0.210 |
Why?
|
Neoplasms | 5 | 2023 | 22170 | 0.200 |
Why?
|
Office Visits | 1 | 2006 | 595 | 0.200 |
Why?
|
Colorectal Neoplasms | 7 | 2023 | 6935 | 0.200 |
Why?
|
Financing, Government | 2 | 2016 | 472 | 0.200 |
Why?
|
Risk Management | 3 | 2024 | 558 | 0.200 |
Why?
|
Sensitivity and Specificity | 7 | 2020 | 14666 | 0.200 |
Why?
|
New Mexico | 3 | 2018 | 83 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3205 | 0.190 |
Why?
|
Advisory Committees | 2 | 2018 | 787 | 0.190 |
Why?
|
Suicide | 1 | 2012 | 1601 | 0.180 |
Why?
|
Kenya | 2 | 2014 | 758 | 0.180 |
Why?
|
Life Expectancy | 2 | 2018 | 1242 | 0.180 |
Why?
|
Viral Vaccines | 1 | 2006 | 596 | 0.180 |
Why?
|
Occult Blood | 3 | 2017 | 198 | 0.170 |
Why?
|
Male | 32 | 2023 | 360804 | 0.160 |
Why?
|
Psychotherapy, Brief | 1 | 2020 | 118 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2004 | 787 | 0.150 |
Why?
|
Geography | 1 | 2020 | 656 | 0.150 |
Why?
|
Carcinoembryonic Antigen | 1 | 2019 | 337 | 0.150 |
Why?
|
Politics | 1 | 2024 | 815 | 0.150 |
Why?
|
Nicaragua | 1 | 2017 | 29 | 0.150 |
Why?
|
Endometrial Neoplasms | 1 | 2007 | 1366 | 0.140 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2015 | 297 | 0.140 |
Why?
|
Africa, Northern | 2 | 2013 | 86 | 0.140 |
Why?
|
Time Factors | 6 | 2018 | 39967 | 0.140 |
Why?
|
Breast Neoplasms | 8 | 2023 | 21012 | 0.140 |
Why?
|
Algorithms | 1 | 2017 | 14031 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10209 | 0.140 |
Why?
|
Immunity, Herd | 1 | 2016 | 46 | 0.130 |
Why?
|
Middle East | 2 | 2013 | 231 | 0.130 |
Why?
|
Survival Rate | 3 | 2019 | 12725 | 0.130 |
Why?
|
Lebanon | 1 | 2016 | 245 | 0.130 |
Why?
|
Age of Onset | 2 | 2020 | 3305 | 0.130 |
Why?
|
Cryosurgery | 2 | 2018 | 474 | 0.130 |
Why?
|
Triage | 3 | 2023 | 986 | 0.130 |
Why?
|
Forecasting | 2 | 2020 | 2928 | 0.130 |
Why?
|
Penile Neoplasms | 2 | 2013 | 161 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1051 | 0.120 |
Why?
|
Income | 3 | 2020 | 1877 | 0.120 |
Why?
|
Hysterectomy | 1 | 2020 | 857 | 0.120 |
Why?
|
Brazil | 3 | 2007 | 1230 | 0.120 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4761 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 463 | 0.120 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 7827 | 0.120 |
Why?
|
Research Support as Topic | 2 | 2015 | 697 | 0.120 |
Why?
|
Asia, Central | 1 | 2013 | 13 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1032 | 0.120 |
Why?
|
Africa South of the Sahara | 2 | 2013 | 744 | 0.110 |
Why?
|
Europe, Eastern | 1 | 2013 | 72 | 0.110 |
Why?
|
Biomedical Technology | 1 | 2016 | 211 | 0.110 |
Why?
|
Treatment Outcome | 8 | 2022 | 64680 | 0.110 |
Why?
|
Likelihood Functions | 1 | 2017 | 992 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2015 | 2220 | 0.110 |
Why?
|
Mental Disorders | 1 | 2014 | 6845 | 0.110 |
Why?
|
Policy Making | 1 | 2017 | 542 | 0.110 |
Why?
|
Vaginal Neoplasms | 1 | 2013 | 104 | 0.110 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13380 | 0.110 |
Why?
|
Social Class | 2 | 2023 | 2004 | 0.110 |
Why?
|
Cross Protection | 1 | 2012 | 25 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.110 |
Why?
|
South Africa | 1 | 2018 | 1842 | 0.110 |
Why?
|
Pregnancy | 6 | 2024 | 29874 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1475 | 0.100 |
Why?
|
Mitral Valve | 1 | 2021 | 1465 | 0.100 |
Why?
|
Virology | 1 | 2012 | 75 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1584 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2571 | 0.100 |
Why?
|
Prevalence | 5 | 2021 | 15732 | 0.100 |
Why?
|
Risk Factors | 7 | 2018 | 74206 | 0.100 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 412 | 0.100 |
Why?
|
rab GTP-Binding Proteins | 1 | 2013 | 250 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1386 | 0.100 |
Why?
|
Age Distribution | 3 | 2017 | 2880 | 0.090 |
Why?
|
Military Personnel | 1 | 2020 | 1246 | 0.090 |
Why?
|
Decision Trees | 2 | 2009 | 504 | 0.090 |
Why?
|
Quality Improvement | 2 | 2016 | 3801 | 0.090 |
Why?
|
Stress, Psychological | 2 | 2015 | 4481 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 914 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2426 | 0.090 |
Why?
|
Women's Health | 2 | 2011 | 2065 | 0.080 |
Why?
|
Program Evaluation | 2 | 2016 | 2495 | 0.080 |
Why?
|
Program Development | 1 | 2016 | 1297 | 0.080 |
Why?
|
Ethiopia | 2 | 2021 | 464 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11121 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2017 | 3600 | 0.080 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 413 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 385 | 0.080 |
Why?
|
Spain | 1 | 2010 | 487 | 0.080 |
Why?
|
Biopsy | 2 | 2018 | 6766 | 0.080 |
Why?
|
Pacific Islands | 1 | 2008 | 52 | 0.080 |
Why?
|
China | 1 | 2015 | 2369 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15266 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4915 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2018 | 2180 | 0.080 |
Why?
|
Genotype | 2 | 2020 | 12990 | 0.080 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1402 | 0.080 |
Why?
|
Pharyngeal Neoplasms | 1 | 2008 | 113 | 0.080 |
Why?
|
Hong Kong | 2 | 2007 | 166 | 0.070 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 395 | 0.070 |
Why?
|
Homosexuality, Male | 2 | 2019 | 1334 | 0.070 |
Why?
|
Vietnam | 1 | 2008 | 409 | 0.070 |
Why?
|
Costa Rica | 2 | 2021 | 180 | 0.070 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 1134 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 13506 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.070 |
Why?
|
Asia | 1 | 2008 | 619 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3223 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.070 |
Why?
|
DNA Probes, HPV | 1 | 2006 | 21 | 0.070 |
Why?
|
Quality of Life | 3 | 2021 | 13367 | 0.070 |
Why?
|
Consensus | 3 | 2024 | 3123 | 0.070 |
Why?
|
Immunization | 1 | 2010 | 1228 | 0.070 |
Why?
|
Mammography | 3 | 2017 | 2430 | 0.060 |
Why?
|
Registries | 3 | 2018 | 8224 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20098 | 0.060 |
Why?
|
Autophagy | 1 | 2013 | 1326 | 0.060 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 559 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58976 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2358 | 0.060 |
Why?
|
Sierra Leone | 2 | 2015 | 169 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
National Health Programs | 1 | 2008 | 440 | 0.060 |
Why?
|
Finland | 1 | 2006 | 607 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6019 | 0.060 |
Why?
|
Actuarial Analysis | 1 | 2004 | 372 | 0.060 |
Why?
|
Infant | 4 | 2023 | 36192 | 0.060 |
Why?
|
France | 1 | 2005 | 497 | 0.060 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2013 | 1841 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 495 | 0.060 |
Why?
|
Reproductive Health Services | 1 | 2024 | 87 | 0.060 |
Why?
|
Students | 2 | 2018 | 1741 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2010 | 2707 | 0.050 |
Why?
|
Caregivers | 1 | 2015 | 2237 | 0.050 |
Why?
|
Italy | 1 | 2005 | 842 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2008 | 596 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8631 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4016 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4527 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3889 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2021 | 70 | 0.050 |
Why?
|
Pakistan | 1 | 2021 | 292 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39106 | 0.040 |
Why?
|
Hospitalization | 2 | 2010 | 10723 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8529 | 0.040 |
Why?
|
Risk Assessment | 4 | 2020 | 23995 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2010 | 2775 | 0.040 |
Why?
|
Cohort Studies | 5 | 2018 | 41487 | 0.040 |
Why?
|
Colonoscopy | 1 | 2007 | 1394 | 0.040 |
Why?
|
Nigeria | 1 | 2021 | 770 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4244 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14605 | 0.040 |
Why?
|
Standard of Care | 1 | 2020 | 551 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2002 | 970 | 0.030 |
Why?
|
Length of Stay | 1 | 2010 | 6425 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10552 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1336 | 0.030 |
Why?
|
Self Care | 1 | 2020 | 796 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 80636 | 0.030 |
Why?
|
Cryotherapy | 1 | 2016 | 159 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3429 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1450 | 0.030 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2024 | 1188 | 0.030 |
Why?
|
Societies, Medical | 2 | 2020 | 3905 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 267 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2020 | 26198 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1322 | 0.030 |
Why?
|
Conduct Disorder | 1 | 2015 | 245 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2331 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11118 | 0.030 |
Why?
|
Public Policy | 1 | 2016 | 559 | 0.020 |
Why?
|
Physical Examination | 1 | 2018 | 1255 | 0.020 |
Why?
|
Africa, Eastern | 1 | 2011 | 76 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2013 | 405 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42230 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1497 | 0.020 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2013 | 495 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1750 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3060 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1190 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2901 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2012 | 447 | 0.020 |
Why?
|
Primary Prevention | 1 | 2016 | 1186 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4061 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2696 | 0.020 |
Why?
|
Lysosomes | 1 | 2013 | 924 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1967 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1126 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20570 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2012 | 1626 | 0.020 |
Why?
|
Survival Analysis | 2 | 2011 | 10090 | 0.020 |
Why?
|
Direct Service Costs | 1 | 2006 | 59 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5871 | 0.020 |
Why?
|
Lung | 1 | 2023 | 10000 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8830 | 0.020 |
Why?
|
Insurance, Health | 1 | 2016 | 2498 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2013 | 2688 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1702 | 0.010 |
Why?
|
Anxiety | 1 | 2015 | 4573 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3688 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9053 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11076 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8465 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54425 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7856 | 0.010 |
Why?
|
Depression | 1 | 2015 | 8124 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17904 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30052 | 0.000 |
Why?
|
Prognosis | 1 | 2004 | 29625 | 0.000 |
Why?
|